[go: up one dir, main page]

AU2002221882A1 - Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors - Google Patents

Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors

Info

Publication number
AU2002221882A1
AU2002221882A1 AU2002221882A AU2188202A AU2002221882A1 AU 2002221882 A1 AU2002221882 A1 AU 2002221882A1 AU 2002221882 A AU2002221882 A AU 2002221882A AU 2188202 A AU2188202 A AU 2188202A AU 2002221882 A1 AU2002221882 A1 AU 2002221882A1
Authority
AU
Australia
Prior art keywords
methylglutaryl
coenzyme
hydroxyl
reductase inhibitors
reductase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002221882A
Other languages
English (en)
Inventor
August Bernd
Roland Kaufmann
Stefan Kippenberger
Stefan Loitsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Goethe Universitaet Frankfurt am Main
Original Assignee
Goethe Universitaet Frankfurt am Main
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Goethe Universitaet Frankfurt am Main filed Critical Goethe Universitaet Frankfurt am Main
Publication of AU2002221882A1 publication Critical patent/AU2002221882A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2002221882A 2000-11-21 2001-11-21 Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors Abandoned AU2002221882A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10057648 2000-11-21
DE2000157648 DE10057648A1 (de) 2000-11-21 2000-11-21 Verwendung von Inhibitoren von 3-Hydroxyl-3-methylglutaryl-Coenzym-A-Reduktase
PCT/EP2001/013569 WO2002041916A2 (fr) 2000-11-21 2001-11-21 Utilisation d'inhibiteurs de 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase

Publications (1)

Publication Number Publication Date
AU2002221882A1 true AU2002221882A1 (en) 2002-06-03

Family

ID=7664050

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002221882A Abandoned AU2002221882A1 (en) 2000-11-21 2001-11-21 Use of 3-hydroxyl-3-methylglutaryl-coenzyme-a-reductase inhibitors

Country Status (3)

Country Link
AU (1) AU2002221882A1 (fr)
DE (1) DE10057648A1 (fr)
WO (1) WO2002041916A2 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009534459A (ja) 2006-04-26 2009-09-24 ローズモント・フアーマシユーテイカルズ・リミテツド 液体経口組成物
GB2459922A (en) * 2008-05-13 2009-11-18 Univ Dundee Treatment for keratinizing dermatological disorders by reduction in keratin expression
CN110327285A (zh) * 2019-07-15 2019-10-15 张正华 他汀类药膏的制备方法及其在治疗汗孔角化症中的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT642341E (pt) * 1992-05-13 2001-01-31 Us Health Utilizacao de inibidores de redutase de 3-hidroxi-3-metilglutaril coenzima a no tratamento de cancro

Also Published As

Publication number Publication date
DE10057648A1 (de) 2002-06-06
WO2002041916A2 (fr) 2002-05-30

Similar Documents

Publication Publication Date Title
GB0025782D0 (en) Use of inhibitors
AU2001258771A1 (en) -secretase inhibitors
AU2001244399A1 (en) Gamma-secretase inhibitors
AU2002213485A1 (en) Inhibitors of protein kinases
AU2001237041A1 (en) Kinase inhibitors
AU2001244355A1 (en) Heterobiarylsulphonamides and their use as pde 7 inhibitors
AU2002220241A1 (en) Parb inhibitors
AU2001234088A1 (en) TNF-alpha inhibitors
AU8969601A (en) New use of lipase inhibitors
AU2002211663A1 (en) Nf-$g(k)b inhibitors
HUP0300061A3 (en) Use of il-18 inhibitors
AU2002224808A1 (en) Use of thienopyrimidines
AU2001247589A1 (en) Non-amidine containing protease inhibitors
AU2001285750A1 (en) Urokinase inhibitors
AU2001236052A1 (en) Urease inhibitors
AU2001228703A1 (en) Use of cox-2 inhibitors for the treatment of constipation
AU2002222627A1 (en) Tak1 inhibitors
AU2002337913A1 (en) Glycosulfopeptide inhibitors and methods of use thereof
AU2001255090A1 (en) Cdk inhibitors having 3-hydroxychromen-4-one structure
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2001244562A1 (en) Neovascularization inhibitors
AU2002214038A1 (en) Inhibitors of transglutaminases
AU2002224550A1 (en) Corrosion inhibitors
AU2001232245A1 (en) Tnf- alpha inhibitors
AU2002222933A1 (en) Inhibitors of factor xa